EDITORIAL
Published on 27 Jan 2022
Editorial: Treatment for Non-Small Cell Lung Cancer in Distinct Patient Populations
doi 10.3389/fonc.2022.838570
- 942 views
- 4 citations
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Treatment for Non Small Cell Lung Cancer in Distinct Patient Populations
Treatment for Non Small Cell Lung Cancer in Distinct Patient Populations
39k
Total Downloads
119k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 30 Nov 2021
The Prognostic Role of Blood Inflammatory Biomarkers and EGFR Mutation Status in Stage IIIA/N2 Non-Small Cell Lung Cancer Patients Treated With Trimodality Therapy
doi 10.3389/fonc.2021.707041
- 1,639 views
- 10 citations
ORIGINAL RESEARCH
Published on 22 Sep 2021
Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung
doi 10.3389/fonc.2021.714549
- 2,063 views
- 6 citations
ORIGINAL RESEARCH
Published on 15 Sep 2021
Clinical Outcome of CT-Guided Stereotactic Ablative Brachytherapy for Unresectable Early Non-Small Cell Lung Cancer: A Retrospective, Multicenter Study
doi 10.3389/fonc.2021.706242
- 1,722 views
- 5 citations
SYSTEMATIC REVIEW
Published on 13 Sep 2021
An Indirect Comparison Between Nivolumab + Ipilimumab + Two Cycles of Chemotherapy vs. Pembrolizumab + Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer
doi 10.3389/fonc.2021.698199
- 5,339 views
- 5 citations
MINI REVIEW
Published on 23 Aug 2021
Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue
doi 10.3389/fonc.2021.704084
- 7,178 views
- 12 citations
ORIGINAL RESEARCH
Published on 16 Aug 2021
Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations
doi 10.3389/fonc.2021.681429
- 1,879 views
- 12 citations
SYSTEMATIC REVIEW
Published on 06 Aug 2021
Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020
doi 10.3389/fonc.2021.702216
- 5,579 views
- 19 citations
ORIGINAL RESEARCH
Published on 28 Jul 2021
AI-Based Drug Discovery of TKIs Targeting L858R/T790M/C797S-Mutant EGFR in Non-small Cell Lung Cancer
doi 10.3389/fphar.2021.660313
- 3,850 views
- 9 citations
ORIGINAL RESEARCH
Published on 19 Jul 2021
Development and External Validation of a Nomogram for Predicting Cancer-Specific Survival of Non-Small Cell Lung Cancer Patients With Ipsilateral Pleural Dissemination
doi 10.3389/fonc.2021.645486
- 1,961 views
- 8 citations
SYSTEMATIC REVIEW
Published on 15 Jul 2021
Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
doi 10.3389/fonc.2021.680615
- 3,065 views
- 13 citations
ORIGINAL RESEARCH
Published on 29 Jun 2021
First-Line Chemo-Immunotherapy for Extensive-Stage Small-Cell Lung Cancer: A United States-Based Cost-Effectiveness Analysis
doi 10.3389/fonc.2021.699781
- 3,897 views
- 21 citations
Published in
Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Thoracic Oncology
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 119kTopic views
- 78kArticle views
- 39kArticle downloads